Total study duration will be up to 48 weeks. During Step 1 (on-HCV treatment), all participants will have study visits at Weeks 2, 4, 6, 8, 10, and 12. Participants in Cohorts A and C will have additional Step 1 study visits at Weeks 16, 20, and 24.